ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Worldwide Sleep Apnea Therapeutics and Diagnostics Industry to 2028 - by Product Type, Industry Verticals and Region - ResearchAndMarkets.com

October 5, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Oct 5, 2021--

The “Global Sleep Apnea Therapeutics and Diagnostics Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering.

This report states that the global sleep apnea therapeutics and diagnostics market would grow with a CAGR of 6.90% in the projected years between 2021 and 2028.

Companies Mentioned

  • BMC Medical Co Ltd
  • Braebon Medical Corporation
  • Cadwell Industries Inc
  • Devilbiss Healthcare LLC
  • Fisher & Paykel Healthcare Corporation Limited
  • GE Healthcare (General Electric Company)
  • Invacare Corporation
  • Itamar Medical Ltd
  • Koninklijke Philips Nv
  • Medtronic plc
  • Nihon Kohden Corporation
  • Signifier Medical Technologies Limited
  • Resmed Inc
  • Smiths Medical Inc
  • Somnomedics GmbH
  • Teleflex Incorporated
  • Vyaire Medical Inc

ADVERTISEMENT

Factors such as the growing awareness regarding the negative impacts of untreated sleep apnea, rise in the geriatric population, and increasing cases of obesity are fueling the growth of the market. Also, the increasing use of gadgets at night-time, which causes sleep disturbances, is another factor contributing to the growth process. However, the high costs of sleep apnea devices, issues with reimbursement, and the lack of adherence to the treatment being recommended by the doctors, are curtailing this progress. On the bright side, the advancements in technology as well as the growing usage of at-home monitoring devices is creating new opportunities for growth.

The global market for sleep apnea therapeutics and diagnostics covers the regions of Latin America, North America, the Middle East and Africa, the Asia-Pacific, and Europe.

The market in the Asia-Pacific is expected to evolve at the fastest rate in the forecast duration. Most of the nations in this region are emerging economies. Presently, they are adopting advanced technologies, and are also improving their healthcare systems. Owing to this, the APAC has been a hub for cheap raw materials, especially for medical device manufacturing companies, including sleep apnea devices. Also, the rising healthcare expenditure and the development in infrastructure are promoting the growth of the Asia-Pacific sleep apnea therapeutics and diagnostics market.

Key Topics Covered:

1. Global Sleep Apnea Therapeutics and Diagnostics Market - Summary

2. Industry Outlook

2.1. Impact of Covid-19 on the Sleep Apnea Therapeutics and Diagnostics Market

2.2. Key Insights

ADVERTISEMENT

2.3. Porter’s Five Forces Model

2.4. Legal, Policy & Regulatory Framework

2.5. Supply Chain Outlook

2.6. Market Attractiveness Index

2.7. Vendor Scorecard

2.8. Key Market Strategies

2.8.1. Acquisitions & Mergers

2.8.2. New Product Launches & Developments

2.8.3. Contracts and Partnerships

2.8.4. Business Expansions, Announcements & Divestitures

2.9. Market Drivers

2.9.1. Awareness Related to the Negative Impact of Untreated Sleep Apnea

2.9.2. Rise in Geriatric Population and Obesity Cases

2.9.3. Disturbed Sleep Due to Increased Use of Gadgets at Night-Time

2.10. Market Challenges

2.10.1. High Cost of Sleep Apnea Devices

2.10.2. Unfavorable Reimbursement Landscape

2.10.3. Lack of Patient Adherence to the Treatment Recommended

2.11. Market Opportunities

2.11.1. Increasing Usage of At-Home Monitoring Devices

2.11.2. Advancements in Technology

3. Global Sleep Apnea Therapeutics and Diagnostics Market - Product Type

3.1. Therapeutics

3.1.1. Positive Airway Pressure (Pap) Devices

3.1.1.1. Continuous Positive Airway Pressure (Cpap) Devices

3.1.1.2. Bilevel Positive Airway Pressure (Bpap) Devices

3.1.2. Oxygen Devices

3.1.2.1. Oxygen Concentrators

3.1.2.2. Portable Oxygen Concentrators

3.1.2.3. Liquid Portable Oxygen

3.1.3. Masks and Accessories

3.1.4. Oral Appliances

3.1.4.1. Mandibular Advancement Devices

3.1.4.2. Tongue Retainers

3.1.5. Adaptive Servo Ventilation (Asv) Devices

3.2. Diagnostics and Monitoring

3.2.1. Polysomnography Device (Psg)

3.2.1.1. Clinical Psg Device

3.2.1.2. Ambulatory Psg Device

3.2.2. Oximeter

3.2.2.1. Tabletop Oximeter

3.2.2.2. Fingertip Oximeter

3.2.2.3. Handheld Oximeter

3.2.2.4. Wrist-Worn Oximeter

3.2.3. Actigraphy Monitoring Device

3.2.4. Respiratory Polygraph

3.2.5. Sleep Apnea Screening Device

3.2.6. Other Diagnostics and Monitoring Devices

4. Global Sleep Apnea Therapeutics and Diagnostics Market - Industry Verticals

4.1. Hospitals & Sleep Laboratories

4.2. Home Care Settings

5. Global Sleep Apnea Therapeutics and Diagnostics Market - Regional Outlook

6. Competitive Landscape

7. Research Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/xklwjb

View source version on businesswire.com:https://www.businesswire.com/news/home/20211005005944/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: GENERAL HEALTH HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 10/05/2021 11:39 AM/DISC: 10/05/2021 11:39 AM

http://www.businesswire.com/news/home/20211005005944/en